scholarly journals Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from mendelian randomisation, transcriptomics and risk genotypes

Author(s):  
Thomas H Julian ◽  
Nicholas Glascow ◽  
A Dylan Fisher Barry ◽  
Tobias Moll ◽  
Calum Harvey ◽  
...  

ABSTRACTBackgroundAmyotrophic lateral sclerosis (ALS) is a universally fatal neurodegenerative disease. ALS is determined by gene-environment interactions and improved understanding of these interactions may lead to effective personalised medicine. The role of physical exercise in the development of ALS is currently controversial.MethodsWe dissected the exercise-ALS relationship in a series of two-sample Mendelian randomisation (MR) experiments. We then we tested for enrichment of ALS genetic risk within exercise-associated transcriptome changes. Finally, we applied a validated physical activity (PA) questionnaire in a small cohort of genetically selected ALS patients.FindingsWe present MR evidence supporting a causal relationship between genetic liability to strenuous leisure-time exercise and ALS (multiplicative random effects IVW, p=0.01). Transcriptomic analysis revealed that genes with altered expression in response to acute exercise are enriched with known ALS risk genes (permutation test, p=0.013) including C9ORF72, and with ALS-associated rare variants of uncertain significance. Questionnaire evidence revealed that age of onset is inversely proportional to historical PA for C9ORF72-ALS (linear regression, t=-2.28, p=0.036) but not for non-C9ORF72-ALS. Moreover, compared to non-C9ORF72-ALS patients and neurologically normal controls, C9ORF72-ALS cases reported the highest minimum average PA (20.9kJ/kg/day) consistent with an exercise threshold for penetrance.InterpretationOur MR approach suggests a positive causal relationship between ALS and physical exercise. Exercise is likely to cause motor neuron injury only in patients with a risk-genotype. Consistent with this we have shown that ALS risk genes are activated in response to exercise. In particular, we propose that G4C2-repeat expansion of C9ORF72 predisposes to exercise-induced ALS.FundingWe acknowledge support from the Wellcome Trust (JCK, 216596/Z/19/Z), NIHR (PJS, NF-SI-0617-10077; IS-BRC-1215-20017) and NIH (MPS, CEGS 5P50HG00773504, 1P50HL083800, 1R01HL101388, 1R01-HL122939, S10OD025212, and P30DK116074, UM1HG009442).RESEARCH IN CONTEXTEvidence before this studyThe role of physical activity (PA) as a risk factor for ALS was evaluated in a systematic review of 26 studies performed by Lacorte et al. in 2016. The authors concluded that there was insufficient evidence to draw a firm conclusion. The authors highlighted limitations of previous studies relating to heterogeneous classification of PA and ALS. They noted that none of the published literature achieved the highest quality rating in the Newcastle Ottawa Scale, which they attribute to methodological challenges posed by the rarity and severity of the disease. Failure to address genetic subtypes of ALS was proposed as a shortcoming in the studies surveyed. To identify more recent publications, we conducted a literature search using the PubMed database for articles published between 01/01/2015 - 11/11/2020. The search terms used were (“Amyotrophic lateral sclerosis”[Title/Abstract] OR “motor neuron disease”[Title/Abstract] OR MND[Title/Abstract] OR ALS[Title/Abstract]) AND (PA[Title/Abstract] OR exercise[Title/Abstract] OR “physical activity”[Title/Abstract] OR sport[Title/Abstract]). This search strategy yielded 182 results and we filtered for original, observational, human-subject studies but we excluded case series with <10 participants and case reports. This process identified 12 further relevant publications which report opposite conclusions without significantly addressing the methodological issues highlighted above. A single recent study used linkage disequilibrium score regression and mendelian randomisation to test for a causal relationship between ALS and a number of UK biobank questionnaire items including participation in light DIY, walking for pleasure and moderate activity duration, but this study did not address the relationship between ALS and strenuous, frequent physical exercise.Added value of this studyIn the present study, we have exploited the methodological advantages of mendelian randomisation (MR) to counter bias, together with a tailored approach to PA exposure aimed at isolating strenuous, frequent physical exercise. We achieved this by selecting and combining UK biobank questionnaire items. In contrast to previous studies, we have addressed the gene-environment interaction by measuring the effect of exercise on expression of ALS risk genes. Furthermore, we have considered in detail the relationship between PA and the most frequent genetic risk factor for ALS: hexanucleotide (G4C2) repeat expansion of C9ORF72. Our data suggests that genetic liability to leisure time physical activity is a risk factor for ALS and C9ORF72-ALS in particular. In addition, we offer evidence that a number of known ALS-associated genetic variants are functionally linked to the physiological response to exercise.Implications of all the available evidenceOur results indicate that participation in leisure time physical activity is a risk factor for ALS particularly in the context of certain risk genotypes. This could explain some of the controversy in previous studies which have largely neglected genetic heterogeneity within ALS patients. Our results form a platform for future research to explore the interaction between specific genotypes and exercise-induced ALS in a prospective manner with larger numbers, and in selected pedigrees. Ultimately this could lead to the design of personalised medicine including lifestyle advice regarding physical activity, to patients with ALS and their family members.

EBioMedicine ◽  
2021 ◽  
Vol 68 ◽  
pp. 103397
Author(s):  
Thomas H Julian ◽  
Nicholas Glascow ◽  
A Dylan Fisher Barry ◽  
Tobias Moll ◽  
Calum Harvey ◽  
...  

Neurology ◽  
2021 ◽  
pp. 10.1212/WNL.0000000000012829
Author(s):  
Angela Rosenbohm ◽  
Raphael Peter ◽  
Johannes Dorst ◽  
Jan Kassubek ◽  
Dietrich Rothenbacher ◽  
...  

Background and Objectives:Whether physical activity (PA) is a risk factor for amyotrophic lateral sclerosis (ALS) is controversial since data on life-long PA are rare. The main objective of this study is to provide insight in PA as a potential risk factor for ALS, reporting data on cumulative PA, leisure time PA and occupational PA. This study also aims at gathering evidence on the role of PA as a prognostic factor in disease course.Methods:Lifetime PA values collected by questionnaires addressing work and leisure time were quantified into metabolic equivalents (MET). A population-based case-control study embedded in the ALS Registry Swabia served to calculate odds ratio (OR) of ALS by PA in different time intervals and prognosis.Results:In ALS cases (393 cases, 791 age- and sex-matched controls), we observed reduced total PA at interview and up to 5 years before interview compared to controls. Total PA was not associated with ALS risk 5-55 years before interview. Heavy occupational work intensity was associated with increased ALS risk (OR=1.97, 95%-CI (1.34, 2.89)). Total PA levels were associated with survival in a nonlinear manner: inactive patients and highest activity levels (25 METh/week) revealed the worst survival time of 15.4/19.3 months, respectively. Best median survival with 29.8 months was seen at 10.5 METh/week after adjusting for other prognostic factors.Discussion:Lifetime combined PA sharply decreased several years before disease onset compared to controls. The risk of developing ALS was not associated with former total PA levels 5-55 years before interview in contrast to occupational PA, probably reflecting work associated exposures. We found a strong nonlinear association of current and pre-diagnostic PA level and survival in ALS cases with the best survival with moderate PA. PA intensity may be a disease modifying factor with an unfavourable outcome in sedentary and hyperactive behaviour.Classification of evidence:This study provides Class III evidence that physical activity was not associated with the development of ALS.


2016 ◽  
Vol 17 (5-6) ◽  
pp. 377-384 ◽  
Author(s):  
Ceryl A. Harwood ◽  
Kate Westgate ◽  
Sue Gunstone ◽  
Soren Brage ◽  
Nicholas J. Wareham ◽  
...  

2020 ◽  
Vol 17 (3) ◽  
pp. 275-285 ◽  
Author(s):  
Si Chen ◽  
Qiao Liao ◽  
Ke Lu ◽  
Jinxia Zhou ◽  
Cao Huang ◽  
...  

Background: Amyotrophic lateral sclerosis (ALS) is a neurological disorder clinically characterized by motor system dysfunction, with intraneuronal accumulation of the TAR DNAbinding protein 43 (TDP-43) being a pathological hallmark. Riluzole is a primarily prescribed medicine for ALS patients, while its therapeutical efficacy appears limited. TDP-43 transgenic mice are existing animal models for mechanistic/translational research into ALS. Methods: We developed a transgenic rat model of ALS expressing a mutant human TDP-43 transgene (TDP-43M337V) and evaluated the therapeutic effect of Riluzole on this model. Relative to control, rats with TDP-43M337V expression promoted by the neurofilament heavy subunit (NEF) gene or specifically in motor neurons promoted by the choline acetyltransferase (ChAT) gene showed progressive worsening of mobility and grip strength, along with loss of motor neurons, microglial activation, and intraneuronal accumulation of TDP-43 and ubiquitin aggregations in the spinal cord. Results: Compared to vehicle control, intragastric administration of Riluzole (30 mg/kg/d) did not mitigate the behavioral deficits nor alter the neuropathologies in the transgenics. Conclusion: These findings indicate that transgenic rats recapitulate the basic neurological and neuropathological characteristics of human ALS, while Riluzole treatment can not halt the development of the behavioral and histopathological phenotypes in this new transgenic rodent model of ALS.


2021 ◽  
pp. 1-5
Author(s):  
João Morgadinho ◽  
Ana Catarina Pronto-Laborinho ◽  
Vasco A. Conceição ◽  
Marta Gromicho ◽  
Susana Pinto ◽  
...  

In amyotrophic lateral sclerosis (ALS) lower plasma creatinine level has been associated with shorter survival and faster functional decline. It has not been clear if creatinine is associated with respiratory outcome. We analyzed retrospectively a population of unselected ALS patients. Multiple-regression and Cox-regression analyses were performed. We included 233 patients, mean age 62.8, mean disease duration of 18.6 months. At baseline, creatinine was significantly associated with ALSFRS-R, but not with its decline rate. No predictive value was disclosed for FVC, or their decline rate, or with survival. We did not confirm that creatinine is a marker of respiratory outcome.


Author(s):  
Georgiana Soares Leandro ◽  
Mário Emílio Teixeira Dourado Júnior ◽  
Glauciane Costa Santana ◽  
Luan Samy Xavier Dantas

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
James C. Dodge ◽  
Jinlong Yu ◽  
S. Pablo Sardi ◽  
Lamya S. Shihabuddin

AbstractAberrant cholesterol homeostasis is implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disease that is due to motor neuron (MN) death. Cellular toxicity from excess cholesterol is averted when it is enzymatically oxidized to oxysterols and bile acids (BAs) to promote its removal. In contrast, the auto oxidation of excess cholesterol is often detrimental to cellular survival. Although oxidized metabolites of cholesterol are altered in the blood and CSF of ALS patients, it is unknown if increased cholesterol oxidation occurs in the SC during ALS, and if exposure to oxidized cholesterol metabolites affects human MN viability. Here, we show that in the SOD1G93A mouse model of ALS that several oxysterols, BAs and auto oxidized sterols are increased in the lumbar SC, plasma, and feces during disease. Similar changes in cholesterol oxidation were found in the cervical SC of sporadic ALS patients. Notably, auto-oxidized sterols, but not oxysterols and BAs, were toxic to iPSC derived human MNs. Thus, increased cholesterol oxidation is a manifestation of ALS and non-regulated sterol oxidation likely contributes to MN death. Developing therapeutic approaches to restore cholesterol homeostasis in the SC may lead to a treatment for ALS.


2021 ◽  
Vol 11 (7) ◽  
pp. 906
Author(s):  
Nimeshan Geevasinga ◽  
Mehdi Van den Bos ◽  
Parvathi Menon ◽  
Steve Vucic

Amyotrophic lateral sclerosis (ALS) is characterised by progressive dysfunction of the upper and lower motor neurons. The disease can evolve over time from focal limb or bulbar onset to involvement of other regions. There is some clinical heterogeneity in ALS with various phenotypes of the disease described, from primary lateral sclerosis, progressive muscular atrophy and flail arm/leg phenotypes. Whilst the majority of ALS patients are sporadic in nature, recent advances have highlighted genetic forms of the disease. Given the close relationship between ALS and frontotemporal dementia, the importance of cortical dysfunction has gained prominence. Transcranial magnetic stimulation (TMS) is a noninvasive neurophysiological tool to explore the function of the motor cortex and thereby cortical excitability. In this review, we highlight the utility of TMS and explore cortical excitability in ALS diagnosis, pathogenesis and insights gained from genetic and variant forms of the disease.


Sign in / Sign up

Export Citation Format

Share Document